163 related articles for article (PubMed ID: 25661085)
1. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
[TBL] [Abstract][Full Text] [Related]
2. VEGF-C in non-small cell lung cancer: meta-analysis.
Jiang H; Shao W; Zhao W
Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
Myong NH
J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis.
Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y
J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765
[TBL] [Abstract][Full Text] [Related]
6. EGFR, TTF-1 and Mdm2 expression in stage III non-small cell lung cancer: a positive association.
Berghmans T; Mascaux C; Haller A; Meert AP; Van Houtte P; Sculier JP
Lung Cancer; 2008 Oct; 62(1):35-44. PubMed ID: 18355939
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis.
Kim JH; Kim HS; Kim BJ; Han B; Choi DR; Kwon JH
J Cancer; 2018; 9(22):4279-4286. PubMed ID: 30519330
[TBL] [Abstract][Full Text] [Related]
8. Cox-2 in non-small cell lung cancer: a meta-analysis.
Jiang H; Wang J; Zhao W
Clin Chim Acta; 2013 Apr; 419():26-32. PubMed ID: 23384501
[TBL] [Abstract][Full Text] [Related]
9. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
Berghmans T; Paesmans M; Mascaux C; Martin B; Meert AP; Haller A; Lafitte JJ; Sculier JP
Ann Oncol; 2006 Nov; 17(11):1673-6. PubMed ID: 16980598
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancer.
Berghmans T; Mascaux C; Martin B; Ninane V; Sculier JP
Lung Cancer; 2006 May; 52(2):219-24. PubMed ID: 16545887
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Jin Y; Sun Y; Shi X; Zhao J; Shi L; Yu X
J Cancer Res Ther; 2014 Nov; 10 Suppl():C160-6. PubMed ID: 25450276
[TBL] [Abstract][Full Text] [Related]
15. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
16. High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer.
Li XB; Yang Y; Zhang HQ; Yue WT; Zhang TM; Lu BH; Li J; Liu Z; Wang QH; Gao Y; Hu AM; Zhang HM; Shi HL; Hu FB; Li BL
Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2231-9. PubMed ID: 26166648
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
18. Prognosis value of HIF-1α expression in patients with non-small cell lung cancer.
Wang Q; Hu DF; Rui Y; Jiang AB; Liu ZL; Huang LN
Gene; 2014 May; 541(2):69-74. PubMed ID: 24631267
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Martins SJ; Takagaki TY; Silva AG; Gallo CP; Silva FB; Capelozzi VL
Lung Cancer; 2009 Apr; 64(1):105-9. PubMed ID: 18801593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
